Charles River Laboratories International, Inc. News Headlines

CRL 
$60.515
*  
0.255
0.42%
Get CRL Alerts
*Delayed - data as of Sep. 16, 2014 15:38 ET  -  Find a broker to begin trading CRL now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    CRL Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Dynavax Down on Heplisav Delay - Analyst Blog
6/11/2013 7:26:34 PM - Zacks.com

MannKind Progresses on Afrezza - Analyst Blog
6/3/2013 6:28:59 PM - Zacks.com

CRL for Endo Health's Aveed - Analyst Blog
6/3/2013 6:27:01 PM - Zacks.com

NICE News for BMY/AstraZeneca - Analyst Blog
5/30/2013 7:26:45 PM - Zacks.com

ANAC's Discussion with FDA for Tavaborole - Analyst Blog
5/30/2013 5:25:48 PM - Zacks.com

Setback for Valeant Pharma - Analyst Blog
5/29/2013 6:29:48 PM - Zacks.com

Good News for Novartis' Ilaris - Analyst Blog
5/15/2013 6:29:55 PM - Zacks.com

Salix Beats on Earnings - Analyst Blog
5/14/2013 10:28:01 AM - Zacks.com

Cramer's Mad Money - 3 Things Driving The Market Higher (5/13/13)
5/14/2013 7:01:00 AM - Seeking Alpha

ABCO Posts Solid 4Q and FY2013 Earnings - Analyst Blog
5/13/2013 10:50:01 AM - Zacks.com

Cramer's Mad Money - 10 Things To Watch In The Week Ahead (5/3/13)
5/5/2013 6:59:00 AM - Seeking Alpha

Cramer's Mad Money - The Most Important Game Changer For 2013 (5/2/13)
5/3/2013 7:10:00 AM - Seeking Alpha

Charles River Misses Estimates in 1Q - Analyst Blog
5/2/2013 1:44:01 PM - Zacks.com

Glaxo-Impax End Rytary Deal - Analyst Blog
4/30/2013 4:48:45 PM - Zacks.com

Data on Teva's Milprosa - Analyst Blog
4/18/2013 7:13:34 PM - Zacks.com

Priority Review for Bayer's Riociguat - Analyst Blog
4/9/2013 4:08:46 PM - Zacks.com

Data Presented on Bayer's ATX-101 - Analyst Blog
4/8/2013 6:10:38 PM - Zacks.com

Glaxo's Flu Vaccine Approved - Analyst Blog
4/8/2013 5:00:01 PM - Zacks.com

Glaxo's Influenza Vaccine Gets CRL - Analyst Blog
4/1/2013 6:50:01 PM - Zacks.com

Japanese Approval for Bayer's drug - Analyst Blog
3/27/2013 2:25:40 PM - Zacks.com

Another CRL for UTHR's Oral Remodulin - Analyst Blog
3/26/2013 4:26:37 PM - Zacks.com

CHMP Positive on Bayer's Xarelto - Analyst Blog
3/25/2013 5:28:43 PM - Zacks.com

Good News for Novartis Candidate - Analyst Blog
3/19/2013 3:46:58 PM - Zacks.com

Loss at OREX Narrower than Expected - Analyst Blog
3/14/2013 5:45:16 PM - Zacks.com

Bayer/JNJ's Xarelto in New Studies - Analyst Blog
3/12/2013 4:10:31 PM - Zacks.com